Showing results filtered by:
29 Results
Sample Application (K08): Al-Adra
https://www.niaid.nih.gov/sites/default/files/1-k08-ai155816-01a1-aladra-application-508.pdf
Last Reviewed: September 13, 2024
Sample Application Striepen Full Application
https://www.niaid.nih.gov/sites/default/files/striepenfull.pdf
Last Reviewed: November 24, 2023
Realizing that traditional laboratory science – aka “bench research” – isn’t for everyone, staff at NIAID's Rocky Mountain Laboratories recently invited two dozen area high school students to experience not only traditional research but also the lesser-known careers that make bench research possible.
Published: June 21, 2024
Harty Application
https://www.niaid.nih.gov/sites/default/files/harty-application.pdf
Last Reviewed: March 28, 2024
Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020
https://www.niaid.nih.gov/sites/default/files/ORWH-Biennial-Report2019-20.pdf
Last Reviewed: March 8, 2022
Sample Application (F31): Putnam
https://www.niaid.nih.gov/sites/default/files/nicoleputnamapplicationF31.pdf
Last Reviewed: January 25, 2023
Jordan Report 20th Anniversary: Accelerated Development of Vaccines 2002
https://www.niaid.nih.gov/sites/default/files/jordan20_2002.pdf
Last Reviewed: December 31, 2002
Sample application (R15): Mohammad Ayoub Mir
https://www.niaid.nih.gov/sites/default/files/R15-Mohammad-Ayoub-Mir-Application.pdf
Last Reviewed: August 4, 2017
Sample application (SBIR Fast-Track): Coleman
https://www.niaid.nih.gov/sites/default/files/1r44ai112187-01a1_coleman.pdf
Last Reviewed: November 25, 2022
The Jordan Report: Accelerated Development of Vaccines 2007
https://www.niaid.nih.gov/sites/default/files/jordan2007.pdf
Last Reviewed: August 6, 2019
Sample Application (R21): Michael N. Starnbach
https://www.niaid.nih.gov/sites/default/files/starnbachfull.pdf
Last Reviewed: November 29, 2022
vectorworkshop2023
https://www.niaid.nih.gov/sites/default/files/vectorworkshop2023report_508.pdf
Last Reviewed: September 1, 2023
An overview of sustained antiretroviral therapy (ART) and alternative ART-Free options for HIV remission from NIAID.
Last Reviewed: October 18, 2018
Immunology Interest Group (IIG) Newsletter September 2023
https://www.niaid.nih.gov/sites/default/files/iig-newsletter-september-2023.pdf
Last Reviewed: October 10, 2023
In honor of National Postdoc Appreciation Week 2024, the NIAID Office of Research Training and Development is recognizing NIAID postdocs who enrich the NIAID training community through their outstanding mentorship. Read about the research contributions and mentoring philosophies of several NIAID postdocs who were nominated by their postbac mentees for their exemplary mentorship.
Published: September 16, 2024
Immunology Interest Group (IIG) Newsletter September
https://www.niaid.nih.gov/sites/default/files/iig-newsletter-sept-2022.pdf
Last Reviewed: October 6, 2022
Foreign Organization System (FOS) Review (PDF)
https://www.niaid.nih.gov/sites/default/files/fosenglish.pdf
Last Reviewed: November 26, 2019
Foreign Organization System (FOS) Review (Word)
https://www.niaid.nih.gov/sites/default/files/fosenglish.doc
Last Reviewed: August 6, 2019
On this page, we give you detailed information about writing an effective Research Plan when applying for a NIH grant.
Last Reviewed: January 8, 2025
HIV Vaccines HIV pathogenesis
Last Reviewed: August 10, 2022
The 203 rd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, January 30, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:51 a.m. and
Last Reviewed: February 5, 2024
TBRS is a multidisciplinary group composed of chemists, microbiologists, veterinarians, imaging scientists, and clinicians with a shared objective of improving chemotherapy for tuberculosis (TB) patients. Projects span chemical biology, medicinal chemistry, host-pathogen interactions, animal models of experimental chemotherapy, and experimental medicine clinical studies in TB patients.
Last Reviewed: March 11, 2025
AVRS Meeting Summary, February 2013
https://www.niaid.nih.gov/sites/default/files/summaryfeb2013avrs.pdf
Dr. Barry received his Ph.D. in organic and bio-organic chemistry in 1989 from Cornell University. He joined NIAID following postdoctoral research at Johns Hopkins University. In 1998, he was tenured as chief of the TBRS. Dr. Barry is a member of several editorial boards, has authored more than 300 research publications in tuberculosis, and is the most cited researcher in the field, according to ScienceWatch.com.
Last Reviewed: January 12, 2024
The 205 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 5601 Fishers Lane in the Grand Hall at 10:30 a.m. on Monday, September 11, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public
Last Reviewed: January 11, 2024